Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 5.5B | 5.3B | 5.2B | 5.4B |
Cost of revenue | 2.9B | 3.0B | 2.9B | 3.0B |
Gross profit | 2.6B | 2.3B | 2.2B | 2.5B |
Operating expense | ||||
Research & development | 297M | 302M | 343M | 302M |
Selling general and admin | 1.3B | 1.3B | 1.3B | 1.3B |
Other operating expenses | 38M | 45M | 28M | 136M |
Operating income | 979M | 637M | 546M | 793M |
Non operating interest income | ||||
Income | 5M | 5M | 23M | 55M |
Expense | 152M | 151M | 155M | 155M |
Other income expense | -130M | -128M | -108M | -179M |
Pretax income | 703M | 363M | 306M | 514M |
Tax provision | 129M | 55M | 3M | 114M |
Net income | 574M | 308M | 303M | 400M |
Basic EPS | 2 | 1.1 | 1.1 | 1.5 |
Diluted EPS | 2 | 1.1 | 1.0 | 1.5 |
Basic average shares | 287.2M | 287.3M | 289.5M | 289.6M |
Diluted average shares | 287.2M | 287.7M | 290.4M | 290.6M |
EBITDA | 1.6B | 1.2B | 1.2B | 1.5B |
Net income from continuing op. | 574M | 308M | 303M | 400M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |